Recently I spoke with two international businesses, one Dutch and one Korean. Both were involved in oncology clinical trials. Both were deciding where to run the next phase of development.
HMRC has issued an email alongside an update to the Corporate Intangibles Research and Development Manual. The email is explicit on a critical point. There has been no change to
As 2025 draws to a close, it is clear that this has been one of the most consequential years for UK R&D tax relief since the original SME and RDEC
The 2025 Budget makes it clear that research and development remains central to the United Kingdom’s growth strategy. There are no dramatic headline changes to R&D tax relief rates. However,
The new merged R&D scheme, effective for accounting periods beginning on or after 1 April 2024, reduces the benefit for many SMEs. However, Enhanced R&D Intensive Support (ERIS) continues to
HMRC has launched its Research and Development Expert Advisory Panel (RDEAP), made up of six independent specialists from fields such as advanced manufacturing, life sciences, AI, and technology. The goal
HMRC has recently launched an online tool intended to help businesses determine whether their projects include activities that qualify as research and development for tax purposes. The tool can be
From 1 April 2024, the UK’s merged R&D scheme brought strict limits on overseas subcontractor and externally provided worker costs. However, the law recognises that in some cases, qualifying R&D
From 1 April 2024, the UK’s two R&D tax relief schemes—the SME scheme and the RDEC—were replaced by a single merged regime. The new rules apply in full to all